合成生物学
药物发现
透视图(图形)
数据科学
药物开发
工程伦理学
制药工业
生物
计算生物学
风险分析(工程)
计算机科学
药品
生物技术
生物信息学
业务
工程类
人工智能
药理学
作者
Florian David,A. M. Davis,Michael Gossing,Martin A. Hayes,Elvira Romero,Louis H. Scott,Mark Wigglesworth
标识
DOI:10.1177/24725552211000669
摘要
The global impact of synthetic biology has been accelerating, because of the plummeting cost of DNA synthesis, advances in genetic engineering, growing understanding of genome organization, and explosion in data science. However, much of the discipline's application in the pharmaceutical industry remains enigmatic. In this review, we highlight recent examples of the impact of synthetic biology on target validation, assay development, hit finding, lead optimization, and chemical synthesis, through to the development of cellular therapeutics. We also highlight the availability of tools and technologies driving the discipline. Synthetic biology is certainly impacting all stages of drug discovery and development, and the recognition of the discipline's contribution can further enhance the opportunities for the drug discovery and development value chain.
科研通智能强力驱动
Strongly Powered by AbleSci AI